tiprankstipranks
Connect Biopharma Holdings (CNTB)
NASDAQ:CNTB
US Market
CNTB
Connect Biopharma Holdings
RESEARCH TOOLSreports
Want to see CNTB full AI Analyst Report?

Connect Biopharma Holdings (CNTB) Ratios

147 Followers

Connect Biopharma Holdings Ratios

CNTB's free cash flow for Q4 2025 was $0.00. For the 2025 fiscal year, CNTB's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Mar 25Dec 23Dec 22
Liquidity Ratios
Current Ratio
 3.74 3.74 11.46 4.85 9.97
Quick Ratio
 3.74 3.74 11.46 4.85 10.37
Cash Ratio
 2.82 2.82 9.25 4.18 5.06
Solvency Ratio
 -1.96 -3.89 -1.64 -2.35 -6.87
Operating Cash Flow Ratio
 -3.76 -3.76 -2.79 -1.89 -6.25
Short-Term Operating Cash Flow Coverage
 0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
$ 36.83M$ 36.83M$ 87.84M$ 97.70M$ 141.66M
Leverage Ratios
Debt-to-Assets Ratio
 0.01 0.01 <0.01 <0.01 <0.01
Debt-to-Equity Ratio
 0.02 0.02 <0.01 <0.01 >-0.01
Debt-to-Capital Ratio
 0.02 0.02 <0.01 <0.01 >-0.01
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.34 1.34 1.10 1.25 -0.38
Debt Service Coverage Ratio
 0.00 0.00 0.00 0.00 -5.58K
Interest Coverage Ratio
 0.00 0.00 0.00 0.00 -5.59K
Debt to Market Cap
 0.00 0.00 0.00 0.00 0.00
Interest Debt Per Share
 0.01 0.01 <0.01 <0.01 <0.01
Net Debt to EBITDA
 1.32 0.66 3.58 1.80 0.68
Profitability Margins
Gross Profit Margin
100.00%100.00%100.00%0.00%0.00%
EBIT Margin
-60312.50%-90740.63%-86.24%0.00%0.00%
EBITDA Margin
-59579.17%-89640.63%-83.71%0.00%0.00%
Operating Profit Margin
-60312.50%-90740.63%-86.24%0.00%0.00%
Pretax Profit Margin
-58179.17%-86379.69%-59.17%0.00%0.00%
Net Profit Margin
-58350.00%-86687.50%-60.03%0.00%0.00%
Continuous Operations Profit Margin
-58350.00%-86687.50%-60.03%0.00%0.00%
Net Income Per EBT
100.29%100.36%101.45%100.20%100.26%
EBT Per EBIT
96.46%95.19%68.61%95.66%98.69%
Return on Assets (ROA)
-49.95%-98.94%-15.43%-47.27%-65.77%
Return on Equity (ROE)
-49.43%-132.16%-16.96%-58.89%25.10%
Return on Capital Employed (ROCE)
-68.18%-136.77%-24.19%-61.70%-73.03%
Return on Invested Capital (ROIC)
-67.67%-135.74%-24.15%-60.64%-72.94%
Return on Tangible Assets
-49.99%-99.02%-15.44%-47.29%-66.99%
Earnings Yield
-20.97%-35.35%-20.51%-91.57%-243.66%
Efficiency Ratios
Receivables Turnover
 0.30 0.40 24.77 0.00 0.00
Payables Turnover
 0.00 0.00 0.00 0.13 0.09
Inventory Turnover
 0.00 0.00 0.00 0.00 -0.16
Fixed Asset Turnover
 0.01 0.01 6.14 0.00 0.00
Asset Turnover
 <0.01 <0.01 0.26 0.00 0.00
Working Capital Turnover Ratio
 <0.01 <0.01 0.28 0.00 0.00
Cash Conversion Cycle
 1.22K 918.20 14.74 -2.83K -6.50K
Days of Sales Outstanding
 1.22K 918.20 14.74 0.00 0.00
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 -2.27K
Days of Payables Outstanding
 0.00 0.00 0.00 2.83K 4.23K
Operating Cycle
 1.22K 918.20 14.74 0.00 -2.27K
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.92 -0.92 -0.43 -0.87 -1.80
Free Cash Flow Per Share
 -0.93 -0.93 -0.44 -0.88 -1.88
CapEx Per Share
 <0.01 <0.01 0.01 <0.01 0.08
Free Cash Flow to Operating Cash Flow
 1.01 1.01 1.03 1.01 1.04
Dividend Paid and CapEx Coverage Ratio
 -117.99 -117.99 -31.48 -163.03 -23.18
Capital Expenditure Coverage Ratio
 -117.99 -117.99 -31.48 -163.03 -23.18
Operating Cash Flow Coverage Ratio
 -74.21 -74.21 -132.65 -103.08 -226.71
Operating Cash Flow to Sales Ratio
 -1.07K -800.09 -0.91 0.00 0.00
Free Cash Flow Yield
-38.07%-32.90%-31.97%-74.21%-216.73%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -5.01 -2.83 -4.88 -1.09 -0.41
Price-to-Sales (P/S) Ratio
 2.97K 2.45K 2.93 0.00 0.00
Price-to-Book (P/B) Ratio
 3.34 3.74 0.83 0.64 -0.10
Price-to-Free Cash Flow (P/FCF) Ratio
 -2.76 -3.04 -3.13 -1.35 -0.46
Price-to-Operating Cash Flow Ratio
 -2.74 -3.07 -3.23 -1.36 -0.48
Price-to-Earnings Growth (PEG) Ratio
 0.04 -0.01 0.07 0.01 <0.01
Price-to-Fair Value
 3.34 3.74 0.83 0.64 -0.10
Enterprise Value Multiple
 -3.66 -2.08 0.09 0.69 0.27
Enterprise Value
 98.00M 119.31M -1.86M -40.22M -32.16M
EV to EBITDA
 -3.43 -2.08 0.09 0.69 0.27
EV to Sales
 2.04K 1.86K -0.07 0.00 0.00
EV to Free Cash Flow
 -1.90 -2.31 0.08 0.83 0.31
EV to Operating Cash Flow
 -1.91 -2.33 0.08 0.84 0.32
Tangible Book Value Per Share
 0.75 0.75 1.67 1.83 2.85
Shareholders’ Equity Per Share
 0.75 0.75 1.67 1.83 -8.43
Tax and Other Ratios
Effective Tax Rate
 >-0.01 >-0.01 -0.01 >-0.01 >-0.01
Revenue Per Share
 <0.01 <0.01 0.47 0.00 0.00
Net Income Per Share
 -0.50 -1.00 -0.28 -1.08 -2.11
Tax Burden
 1.00 1.00 1.01 1.00 1.00
Interest Burden
 0.96 0.95 0.69 1.00 0.98
Research & Development to Revenue
 417.81 590.59 1.12 0.00 0.00
SG&A to Revenue
 186.31 317.81 0.74 0.00 0.00
Stock-Based Compensation to Revenue
 77.63 58.22 0.26 0.00 0.00
Income Quality
 0.92 0.92 1.51 0.81 0.85
Currency in USD